Shimadzu Corporation

7701

JP3357200009

Office Equipment

Delayed Japan Exchange Other stock markets 02:00:00 2024-04-19 am EDT			5-day change	1st Jan Change
4,104 ^JPY	-2.05%		-1.77%	+4.11%

Feb. 28	Shimadzu Corporation acquired Gas chromatograph (GC) catalytic microreactor Business from Activated Research Company, LLC.	CI
2023	Certain Common Stock of AR advanced technology, Inc. are subject to a Lock-Up Agreement Ending on 19-DEC-2023.	CI

Shimadzu : Consolidated Financial Statements for the Year Ended March 31, 2022 and Independent Auditor’s Report

July 24, 2022 at 11:34 pm EDT

Shimadzu Corporation and Consolidated Subsidiaries

Consolidated Financial Statements for the Year Ended March 31, 2022 and Independent Auditor's Report

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Original Link
Original Document
Permalink

Disclaimer

Shimadzu Corporation published this content on 25 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 July 2022 03:33:04 UTC.

Latest news about Shimadzu Corporation

Shimadzu Corporation acquired Gas chromatograph (GC) catalytic microreactor Business from Activated Research Company, LLC.	Feb. 27	CI
Certain Common Stock of AR advanced technology, Inc. are subject to a Lock-Up Agreement Ending on 19-DEC-2023.	Dec. 18	CI
MiCAN Technologies Inc. announced that it has received ¥200 million in funding from RealTechJapan LLC., Fujimori Kogyo Co., Ltd., Shimadzu Corporation	23-08-06	CI
IMMUNOSENS Co. Ltd. announced that it has received funding from Global Brain Co., Ltd., Shimadzu Corporation	23-07-25	CI
AR advanced technology, Inc. has completed an IPO in the amount of Â¥924.21 million.	23-06-23	CI
Shyld AI and Shimadzu Corporation Team Up with the Goal of Revolutionizing Healthcare with Groundbreaking AI-Powered UV-C Disinfection Technology	23-06-22	CI
Jefferies Adjusts Shimadzu's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy	23-06-12	MT
Shimadzu Corporation acquired Biomaneo.	23-06-08	CI
AR advanced technology, Inc. has filed an IPO.	23-05-19	CI
Shimadzu Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-10	CI
Jefferies Adjusts Shimadzu's Price Target to 5,000 Yen From 5,500 Yen, Keeps at Buy	23-02-27	MT
New entries in the Asia Investor Portfolio	22-12-07
Shimadzu Corp. Shares Rise on Higher First-Half Profit	22-11-07	DJ
Shimadzu Corporation completed the acquisition of 34.7% stake in Nissui Pharmaceutical Co., Ltd. for ¥13.3 billion.	22-07-27	CI
Shimadzu Corporation made an offer to acquire a 45.9% stake in Nissui Pharmaceutical Co., Ltd. for ¥17.6 billion.	22-05-30	CI
Shimadzu Shares Rise Sharply After Fiscal-Year Net Profit Rose 31%	22-05-10	DJ
Rakuten Medical, Inc. and Shimadzu Corporation Enrolls First Patient in the U.S. Clinical Trial of Photoimmunotherapy	22-02-15	CI
Shimadzu Corporation Revises Earnings Guidance for the Year 2022	21-11-07	CI
Shimadzu Corporation Provides Interim and Full Year Dividend Guidance 2022	21-11-07	CI
Rakuten Medical and Shimadzu Corporation Announce A Joint Development and Commercialization Agreement	21-06-17	CI
Shimadzu Corporation Revises Earnings Guidance for the Fiscal Year Ending March 2021	21-02-05	CI
Shimadzu Corporation Plans to Pay Year End Dividend for the Fiscal Year Ending March 2021	21-02-05	CI
Shimadzu Corporation Announces Earnings Results for the Third Quarter of Fiscal Year 2021	21-02-05	CI
Shimadzu and HORIBA to Collaborate on Development and Sales of LC-Raman Analytical and Measuring Instruments	20-08-27	CI
Shimadzu Corporation Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2020	20-08-05	CI

Chart Shimadzu Corporation

Duration

Period

More charts

Company Profile

Shimadzu Corp is a Japan-based company mainly engaged in the research, development, manufacture, sale and maintenance of scientific and precision equipment. The Company has four segments. Testing and Measuring Instruments segment is engaged in the provision of chromatographic analysis systems, mass spectrometry systems, light analysis systems, thermal analysis systems, bio-related analysis systems, water quality measurement systems and others. Medical Equipment segment is engaged in the provision of X-ray television (TV) systems, angiography systems, X-ray imaging systems and others. Aircraft Equipment segment is engaged in the provision of flight control systems, air management systems, cockpit display systems and others. Industrial Equipment segment is engaged in the provision of turbomolecular pumps and others. The Company is also engaged in the leasing and management of real estate business.

Sector

Office Equipment

Calendar

2024-05-09 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Shimadzu Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

4,190 JPY

Average target price

5,176 JPY

Spread / Average Target

+23.53%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Scientific & Precision Equipment

	1st Jan change	Capi.
SHIMADZU CORPORATION	+4.11%	7.99B
TECAN GROUP AG	-6.29%	4.52B
OLINK HOLDING AB	-11.45%	2.77B
JEOL LTD.	+3.17%	2.26B
NINGBO YONGXIN OPTICS CO.,LTD	-27.93%	1.1B
PARK SYSTEMS CORP.	-7.90%	804M
FOCUSED PHOTONICS (HANGZHOU), INC.	-32.24%	666M
MLOPTIC CORP.	-58.43%	658M
PHENIX OPTICAL COMPANY LIMITED	-29.64%	627M
SVG TECH GROUP CO.,LTD.	-36.91%	565M

Scientific & Precision Equipment

Shimadzu Corporation

Equities

7701

JP3357200009

Office Equipment

Shimadzu : Consolidated Financial Statements for the Year Ended March 31, 2022 and Independent Auditor’s Report

EPS Revisions